Identification of a vitamin D3 response element in the fibronectin gene that is bound by a vitamin D3 receptor homodimer

Journal of Cellular Biochemistry

Volumn 60, Issue 3, 1996, Pages 322-333

  Polly, Patsie ^a   Carlberg, Carsten ^b   Eisman, John A ^a   Morrison, Nigel A ^a,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c NONE   (Australia)

Author keywords

fibronectin; homodimer; transcription; VDR; vitamin D regulation

Indexed keywords

CALCITRIOL RECEPTOR; COLECALCIFEROL; FIBRONECTIN; CALCITRIOL; DNA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELLULAR DISTRIBUTION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; REPORTER GENE; TRANSCRIPTION REGULATION; VITAMIN D METABOLISM; ANIMAL; BREAST TUMOR; CARCINOMA; CELL CULTURE; CELL STRAIN 3T3; CHEMISTRY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN CONFORMATION; RAT;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CALCITRIOL; CARCINOMA; DNA; FIBRONECTINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTORS, CALCITRIOL; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029662286     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960301)60:3<322::AID-JCB4>3.0.CO;2-Y     Document Type: Article

References (64)

1. Alexander CM, Werb Z (1989) Proteinases and extracellular matrix remodelling Curr Opin Cell Biol 1:974-982.
2. Baldwin AS (1990): "Analysis of Sequence-Specific DNA-Binding Proteins by the Gel Mobility Shift Assay." New York.: Wiley-Liss, pp 73-76
3. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267:8943-8949.
4. 3 in C3H/1OT1/2 mouse embryo fibroblasts: Relation to inhibition of proliferation. Exp Cell Res 201:485-493.
5. 3: Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 321:517-527.
6. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W (1993): Two nuclear signalling pathways for vitamin D. Nature 361:657-660.
7. Chomczynski P, Sacchi N (1986): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
8. Dean DC, Newby RF, Bourgeois S (1988): Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor β, and cAMP in human cell lines. J Cell Biol 106:2159-2170.
9. Dignam JD, Lebovitz RM, Roeder RG (1983): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
10. 3 receptor. Cancer Res 44:2103-2109.
11. Dufour S, Duband J, Kornblihtt AR, Thiery JP (1988): The role of fibronectins in embryonic cell migrations. Trends Genet 4:198-203.
12. 3 receptors in breast cancer cells. Lancet 2:1335-1336.
13. Evans RM (1988): The steroid and thyroid receptor superfamily. Science 240:889-895.
14. 3 metabolites. Cancer Res 43:4443-4447.
15. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 123:401-409.
16. 3. J Biol Chem 9:4165-4171.
17. Garner MM, Revzin A (1981): A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: Application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res 9:3047-3060.
18. Gorman CM, Merlino GT, Willingham MC, Pasten I, Howard BH (1982): The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA mediated transfection. Proc Natl Acad Sci USA 79:6777-6781.
19. Green S, Chambon P (1988): Nuclear receptors enhance our understanding of transcriptional regulation. Trends Genet 4:309-314.
20. Hynes RO (ed) (1990): "Fibroneetins." New York: Springer-Verlag.
21. Jones G, Calverly MJ (1993): A dialogue on analogues. New vitamin-D drugs for use in bone disease, psoriasis and cancer. TEM 4:297-302.
22. 3. Proc Natl Acad Sci USA 86:4455-4459.
23. 3 signalling. Nature 355:446-149.
24. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zachareewski T, Chen J-Y, Staub A, Garnier J-M, Mader S, Chambon P (1992): Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395.
25. 3 receptor and other nonreceptor transcription factors. Mol Endocrinol 8:1593-1604.
26. Luckow B, Schütz G (1987): CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 15:5490.
27. MacDonald PN, Haussler CA, Terpering CM, Galligan MA, Reeder MC, Whitfield GK, Haussler MR (1991): Baculovirus-mediated expression of the human vitamin D receptor. J Biol Chem 266:18808-18813.
28. 3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13:5907-5917.
29. Manolagas SC (1987): Vitamin D and its relevance to cancer. Anticancer Res 7:625-638.
30. Marks MS, Hallenbeck PL, Nagata T, Segars JH, Appella E, Nikoderm VM, Ozato K (1992): H-2RIIBP (RXRβ) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone receptors. EMBO J 11:1409-1418.
31. McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT (1985): The role of cell adhesion proteins laminin and fibronectin in the movement of malignant and metastatic cells. Cancer Metastasis Rev 4:125-152.
32. McDonnell S, Matrisian LM (1990): Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 9:305-319.
33. Miao S, Suri PK, Shu-Ling L, Abraham A, Cook N, Milos P, Zern MA (1993): Role of the cyclic AMP response element in rat fibronectin gene expression. Hepatology 17:882-890.
34. Morrison N, Eisman J (1993): Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J Bone Miner Res 8:969-975.
35. Morrison NA, Shine J, Fragonas J, Verkest V, McMenemy ML, Eisman JA (1989): 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the human osteocalcin gene. Science 246:1158-1161.
36. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999.
37. O'Malley BW (1990): The steroid receptor superfamily: More excitement predicted for the future. Mol Endocrinol 4:363-369.
38. Ostrowski LE, Finch J, Krieg P, Matrisian LM, Patskan G, O'Connell JF, Phillips J, Slaga TJ, Breathnach R, Bowden GT (1988): Expression pattern of a gene for a secreted metalloproteinase during late stages of tumour progression. Mol Carcinog 1:13-19.
39. Ozono, K, Liao J, Kerner SA, Scott RA, Pike JW (1990): The vitamin D-responsive element in the human osteocalcin gene. J Biol Chem 265:21881-21888.
40. Patel RS, Odermatt E, Schwarzbauer JE, Hynes RO (1987): Organization of the fibronectin gene provides evidence for exon shuffling during evolution. EMBO J 6:2565-2572.
41. 3 receptor. Proc Natl Acad Sci USA 79:7719-7723.
42. Polly P, Nicholson RC (1993): Sequences of the mouse fibronectin-encoding gene promoter region. Gene 137:353-354.
43. Pothier F, Quellet M, Julien J-P, Guerin SL (1992): An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol 11:83-90.
44. Reddi AH (1984): "Extracellular Matrix and Development." New York: Elselvier.
45. Reichel H, Koeffler P, Norman AW (1989): The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-989.
46. Rodan GA, Rodan SB (1984). "Bone and Mineral Research, Annual II." Amsterdam: Elselvier.
47. Sagami I, Tsai H, Wang M, Tsai B, O'Malley B (1986): Identification of two factors required for transcription of the ovalbumin gene. Mol Cell Biol 6:4259-4267.
48. Sanchez-Lopez R, Nicholson R, Gesnel M, Matrisian LM, Breathnach R (1988): Structure-function relationships in the collagenase family member transin. J Biol Chem 263:11892-11899.
49. Schräder M, Bendik I, Becker-Andre M, Carlberg C (1993): Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem 268:17830-17836.
50. Schräder M, Müller KM, Becker-Andre M, Carlberg C (1994a): Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors. J Mol Endocrinol 12:327-339.
51. Schräder M, Becker-Andre M, Carlberg C (1994b). Thyroid hormone receptor functions as monomeric ligand-induced transcription factor on octameric half-sites. J Biol Chem 269:6444-6449.
52. 3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 370:382-386.
53. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol Cell Biol 15:1154-1161.
54. Schwarzbauer JE, Tamkun JW, Lemischka IR, Hynes RO (1983): Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35:421-431.
55. 3 on matrix and DNA synthesis in condylar cartilage of suckling mice. Calcif Tissue Int 41:95-104.
56. Sleigh MJ (1986): A nonchromatographic assay for the expression of the chloramphenicol acetyl transferase gene in eukaryotie cells. Anal Biochem 156:251-254.
57. Stein GS, Lian JB, Owen TA (1990): Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111-3123.
58. Tryggvason K, Hoyhtya M, Salo T (1987): Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907:191-217.
59. 3 receptor anti-peptide antibodies. J Steroid Biochem Mol Biol 43:649-657.
60. 3 receptors. Cell 65:1255-1266.
61. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z (1990): Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9:203-226.
62. Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R (1979): Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777-785.
63. 3. Biochemistry 27:8521-8526.
64. Yu VC, Delsert C, Anderson B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J-M, Glass CK, Rosenfeld MG (1991). RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 67.1251-1266.